Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks

Completed · Phase 3

Conditions studied: Panic Disorder

In brief

The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.

Key facts

Study ID
NCT00279617
Run by
Lindner Center of HOPE
People needed
15
Starts
2006-01-01
Expected to finish
2009-03-01
Last updated by the study team
2011-12-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.